论文部分内容阅读
意大利学者Paolo Verdecchia等反映肾素血管紧张素转换酶抑制剂(ACEI-I)除了降低血压外,在预防冠心病(CHD)方面优于CCBs,而预防脑卒中则相反。资料先期在《高血压》在线发表。作者认为以前的研究曾提示:某些抗高血压药物可能有独立于降血压之外的心血管裨益。研究者们假设这些
The Italian scholar Paolo Verdecchia et al. Reported that renin-angiotensin-converting enzyme inhibitors (ACEI-I) are superior to CCBs in preventing coronary heart disease (CHD) and stroke prevention in addition to lowering blood pressure. Data pre-published in the “high blood pressure”. The authors believe that previous studies have suggested that certain antihypertensive drugs may have cardiovascular benefits independent of hypotensive effects. Researchers assume these